Ozempic, a diabetes drug popular as a weight-loss drug, has another use that could help tens of millions of Americans, researchers say. In a study published in a journal JAMA Psychiatryresearchers said that if people were using Ozempic or similar drugs known as GLP-1 drugs, they were significantly less likely to be hospitalized for alcohol use disorder. The study looked at 228,000 people in Sweden diagnosed with AUD from 2006 to 2023. NBC News I will report it. All participants were also obese or had type 2 diabetes.
According to the researchers, about 60% of participants were hospitalized for an AUD at some point, but of the 4,300 people who used Ozempic or Wegovy, only about 220 were hospitalized (multiple hospitalizations by an individual). may also have been included). Hospitalization rates for these people were reported to be lower than for people using disulfiram, acamprosate, and naltrexone, which are approved treatments for AUD. USA Today. “We see a huge number of patients who are not getting good results with our drugs and are desperate for treatment for their addictions,” said lead researcher Marc Leteenvuo. “We need more tools in our toolbox.”
About 28 million Americans have Australian dollars, but available drug treatments are “not very good and relapse is very high,” said Alex DiFeliciantonio of Virginia Tech’s Fralin Biomedical Research Institute. . NBC News. Another study published in the same journal said it’s unclear why Ozempic is effective at reducing cravings for alcohol and opioids. addictionBut experts believe the drug may have something to do with how it makes you feel full. Researchers not involved in the Swedish patient study say it is important to conduct more robust research, including randomized controlled clinical trials, before GLP-1 drugs are considered a treatment for AUD. said. (Other Ozempic stories.)
